As part of the HIMSS22 Startup Spotlight series, we speak with Eric Olsen, founder, COO and chairman of Babson Diagnostics. Babson is revolutionizing the testing experience for customers, bringing clinical and laboratory grade testing to more locations using smaller samples than traditional diagnostic testing. In this conversation, we explore a bit of Babson's history, what they are changing about the customer experience, and what the diagnostics industry is feeling in the fallout from Theranos. Be sure to visit Babson at HIMSS22 in Orlando.
The views and opinions expressed in this content or by commenters are those of the author and do not necessarily reflect the official policy or position of HIMSS or its affiliates.